Three scientists have been Declared as the winners of This 2020 Nobel Prize in Physiology or Medicine” for the discovery of the Hepatitis C virus,” the Nobel Committee announced Monday.
“Ahead of their work, the discovery of the Hepatitis A and B viruses were crucial steps ahead, but the vast majority of all blood-borne hepatitis instances remained unsolved. The discovery of the Hepatitis C virus revealed that the origin of the rest of the cases of chronic disease and made potential blood tests and new medications which have saved countless lives.
The Nobel Committee stated the 3 scientists” have made a critical contribution to the struggle against blood-borne hepatitis, a significant international health issue which leads to cirrhosis and liver cancer from people across the globe”
“The Nobel Laureates’ discovery of the Hepatitis C virus is a milestone accomplishment in the continuing struggle against viral diseases,” stated the Nobel Committee. “Due to their discovery, exceptionally sensitive blood tests for the virus are available and those have removed post-transfusion hepatitis in many regions of the world, significantly improving international health. Their discovery also enabled the rapid evolution of antiviral drugs aimed at hepatitis C. For the first time, the disorder can now be cured, increasing hopes of eradicating the Hepatitis C virus in the entire world population. To attain this aim, global efforts easing blood-making and testing antiviral drugs available across the world are going to be required.”
Harvey J. Alter was created in 1935 in New York. He obtained his medical degree at the University of Rochester Medical School and trained in internal medicine at Strong Memorial Hospital and in the University Association of Seattle. 1961he joined the National Institutes of Health (NIH) as a clinical link. He spent a long time at Georgetown University before returning to NIH in 1969 to join the Clinical Center’s Department of Transfusion Medicine as a senior researcher.
Michael Houghton was created in the Uk. He combined G. D. Searle & Company before proceeding to Chiron Corporation, Emeryville, California in 1982. He jumped to the University of Alberta in 2010 and is now a Canada Excellence Research Chair in Virology and the Li Ka Shing Professor of Virology at the University of Alberta where he’s also Director of the Li Ka Shing Applied Virology Institute.
Charles M. Rice was created in 1952 in Sacramento. He also received his Ph.D. degree in 1981 from the California Institute of Technology where he trained as a postdoctoral fellow between 1981-1985. He created his research team at Washington University School of Medicine, St Louis in 1986 and became a full Professor in 1995. Since 2001 he was Professor at the Rockefeller University, New York. Throughout 2001-2018 that he had been the Scientific and Executive Director, Center for the Study of Hepatitis C in Rockefeller University where he remains busy.